All In Biotech

Free tool

FAERS Monitor: Marinol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018651 or its brand name (Marinol, Dronabinol). Reports on generic versions are filed under their own applications.

Reports

8,051

Serious

6,027

75% of reports

Hospitalization

3,111

Death reported

1,678

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea901
  • fatigue716
  • diarrhoea619
  • death599
  • vomiting589
  • off label use523
  • decreased appetite455
  • pain442
  • weight decreased421
  • dyspnoea387
  • asthenia383
  • toxicity to various agents353
  • drug ineffective323
  • headache321
  • drug abuse313

Reports by year received

View as table
YearReports
200489
200584
2006121
2007108
200876
2009102
2010129
2011150
2012181
2013233
2014293
2015429
2016518
2017557
2018664
2019724
2020662
2021542
2022517
2023574
2024562
2025462
2026274

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,108 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug abuseSignal3139.98.82,482
toxicity to various agentsSignal3535.54.91,295
decreased appetiteSignal4555.14.71,521
weight decreasedSignal4213.93.6933
vomitingSignal5893.33.0949
nauseaSignal9013.02.81,225
astheniaSignal3832.72.4403
diarrhoeaSignal6192.52.3576
fatigueSignal7162.42.2608
pain4421.91.7187
death5991.81.7228
dyspnoea3871.81.6137
off label use5231.61.4109
headache3211.31.228
drug ineffective3230.60.669

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.